Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
358 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04880746 | Efficacy and Safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma: a Multicenter Clinical Study | unknown | Phase 3 | 266 | Ruijin HospitalOTHER | 1 | May 11, 2021 | clinicaltrials |
| NCT03158610 | Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer | terminated | Phase 2 / Phase 3 | 20 | Ruijin HospitalOTHER | 1 | May 3, 2021 | clinicaltrials |
| NCT02942706 | Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC | unknown | Phase 2 / Phase 3 | 200 | Ruijin HospitalOTHER | 0 | Apr 30, 2021 | clinicaltrials |
| NCT03959150 | Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer | unknown | Phase 2 / Phase 3 | 231 | Ruijin HospitalOTHER | 1 | Apr 30, 2021 | clinicaltrials |
| NCT04842318 | Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study | unknown | Phase 4 | 789 | Ruijin HospitalOTHER | 1 | Apr 13, 2021 | clinicaltrials |
| NCT04211948 | Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer | unknown | N/A | 300 | Ruijin HospitalOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT04705129 | Zanubrutinib Combined With Tislelizumab in the Treatment of r/r PMBCL and EBV+ DLBCL | unknown | Phase 2 | 40 | Ruijin HospitalOTHER | 1 | Mar 30, 2021 | clinicaltrials |
| NCT04069845 | A Registry Study in Lymphoma Patients Treated With Liposomal Doxorubicin | unknown | — | 2,000 | Ruijin HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04799314 | PD-1 Inhibitor Tislelizumab Maintenance Therapy in R/R DLBCL Patients After ASCT | unknown | Phase 3 | 132 | Ruijin HospitalOTHER | 1 | Mar 16, 2021 | clinicaltrials |
| NCT04781413 | Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer | unknown | Phase 1 / Phase 2 | 38 | Ruijin HospitalOTHER | 1 | Mar 4, 2021 | clinicaltrials |
| NCT03949062 | Study Evaluating the Safety and Efficacy of iR2 in Untreated and Unfit Elderly Patients With DLBCL | unknown | Phase 2 | 30 | Ruijin HospitalOTHER | 1 | Feb 17, 2021 | clinicaltrials |
| NCT04508686 | Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1) | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT04605042 | Comparsion of WT and SNP Techniques of EUS-FNB in Pancreatic Solid Mass (WESP-PSM)(WESP-PSM) | unknown | N/A | 296 | Ruijin HospitalOTHER | 0 | Nov 27, 2020 | clinicaltrials |
| NCT04025593 | Biomarker Guided Treatment in DLBCL | unknown | Phase 2 | 128 | Ruijin HospitalOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT03646591 | Feasibility and Safety of Neoadjuvant Chemotherapy (FLOT ) for Gastric Cancer Patients in China | completed | — | 10 | Ruijin HospitalOTHER | 1 | Nov 13, 2020 | clinicaltrials |
| NCT03363685 | Verification of Novel Survival Prediction Algorithm for Patients With NSCLC Spinal Metastasis | unknown | — | 140 | Ruijin HospitalOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT03365973 | Pathological Fracture in Potentially Unstable Spinal Metastases of Breast Cancer | unknown | — | 120 | Ruijin HospitalOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT04539119 | Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA | unknown | Phase 3 | 120 | Ruijin HospitalOTHER | 1 | Sep 4, 2020 | clinicaltrials |
| NCT04525209 | Integrative Proteomic Characterization of Pancreatic Ductal Adenocarcinoma | unknown | — | 200 | Ruijin HospitalOTHER | 1 | Aug 25, 2020 | clinicaltrials |
| NCT04520295 | ctDNA Screening in Advanced HER2 Positive Gastric Cancer | unknown | — | 100 | Ruijin HospitalOTHER | 1 | Aug 20, 2020 | clinicaltrials |
| NCT04510818 | Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 2) | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Aug 14, 2020 | clinicaltrials |
| NCT04513431 | A Clinical Research of CAR T Cells Targeting CEA Positive Colorectal Cancer (CRC)(CRC) | unknown | Early Phase 1 | 18 | Ruijin HospitalOTHER | 0 | Aug 14, 2020 | clinicaltrials |
| NCT04490668 | Human Albumin and Anastomotic Leakage After Gastric Cancer Surgery | completed | — | 1,049 | Ruijin HospitalOTHER | 0 | Jul 29, 2020 | clinicaltrials |
| NCT04489706 | Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation | unknown | N/A | 20 | Ruijin HospitalOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT04434833 | A Single-cell Transcriptome Study in Patients With Non-Hodgkin's Lymphoma | unknown | — | 150 | Ruijin HospitalOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT04435743 | Efficacy and Safety of Lenalidomide With or Without Rituximab and Other Drugs in B-cell Non-Hodgkin's Lymphomas | unknown | — | 1,000 | Ruijin HospitalOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT04410887 | Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC) | unknown | Phase 1 / Phase 2 | 30 | Ruijin HospitalOTHER | 1 | Jun 1, 2020 | clinicaltrials |
| NCT03639792 | Escorting Octogenarian for Gastric Cancer Surgery | completed | — | 61 | Ruijin HospitalOTHER | 1 | May 22, 2020 | clinicaltrials |
| NCT03606928 | mFLOT Chemotherapy as First-line Treatment in GC | completed | Phase 1 / Phase 2 | 18 | Ruijin HospitalOTHER | 1 | Mar 20, 2020 | clinicaltrials |
| NCT02532400 | Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients(COMPETE) | terminated | Phase 3 | 21 | Ruijin HospitalOTHER | 1 | Mar 11, 2020 | clinicaltrials |
| NCT02951728 | Decitabine Plus R-CHOP in Diffuse Large B-cell Lymphoma(DR-CHOP) | unknown | Phase 1 / Phase 2 | 58 | Ruijin HospitalOTHER | 1 | Mar 11, 2020 | clinicaltrials |
| NCT03367143 | Lenalidomide Plus ICE in the Treatment of Refractory and Relapsed DLBCL | unknown | Phase 2 | 39 | Ruijin HospitalOTHER | 1 | Mar 11, 2020 | clinicaltrials |
| NCT03600363 | A Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma Patients | unknown | Phase 2 | 250 | Ruijin HospitalOTHER | 1 | Mar 11, 2020 | clinicaltrials |
| NCT03930043 | A Metagenome-wide Association Study of Gut Microbiota in Gastrointestinal Non-Hodgkin's Lymphoma Patients | unknown | — | 160 | Ruijin HospitalOTHER | 1 | Mar 11, 2020 | clinicaltrials |
| NCT04096690 | Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma | unknown | Phase 2 | 22 | Ruijin HospitalOTHER | 1 | Mar 11, 2020 | clinicaltrials |
| NCT03413930 | Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer | withdrawn | N/A | 0 | Ruijin HospitalOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT03426514 | Three-port Versus Conventional Laparoscopic Surgery for Colorectal Cancer | unknown | N/A | 282 | Ruijin HospitalOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT03890575 | Airway Segmented Stent Modified With 3D Printing for Malignant Stricture Involving Carina and Distal Bronchi | unknown | N/A | 100 | Ruijin HospitalOTHER | 1 | Feb 11, 2020 | clinicaltrials |
| NCT03882866 | Iodine-125 Seed Implantation Therapy for Locally Advanced Pancreatic Cancer | unknown | N/A | 220 | Ruijin HospitalOTHER | 1 | Feb 6, 2020 | clinicaltrials |
| NCT04236310 | A Study of Neoadjuvant SHR6390 in Combination With Anastrozole, Pyrotinib, and Trastuzumab in Patients With ER+/HER2+ Breast Cancer. | unknown | Phase 2 | 37 | Ruijin HospitalOTHER | 0 | Jan 22, 2020 | clinicaltrials |
| NCT04083079 | Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma | unknown | Phase 4 | 250 | Ruijin HospitalOTHER | 1 | Sep 10, 2019 | clinicaltrials |
| NCT03913312 | Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML | unknown | Phase 1 / Phase 2 | 150 | Ruijin HospitalOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT03715296 | Lenalidomide Based Immunotherapy in the Treatment of DLBCL | unknown | — | 200 | Ruijin HospitalOTHER | 1 | Jul 8, 2019 | clinicaltrials |
| NCT03715309 | R2 in the Treatment of Follicular Lymphoma | unknown | Phase 2 | 115 | Ruijin HospitalOTHER | 1 | Jul 8, 2019 | clinicaltrials |
| NCT03468153 | Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Relapsed and Refractory Lymphoma | unknown | Phase 1 / Phase 2 | 10 | Ruijin HospitalOTHER | 1 | Mar 20, 2018 | clinicaltrials |
| NCT01746992 | CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma | unknown | Phase 4 | 200 | Ruijin HospitalOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT01852435 | R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3B | unknown | Phase 3 | 648 | Ruijin HospitalOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT02542111 | A Study of Bortezomib Plus GDP in the Treatment of Refractory and Relapsed Non-GCB DLBCL | unknown | Phase 2 | 30 | Ruijin HospitalOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT02753543 | Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma | unknown | Phase 2 | 33 | Ruijin HospitalOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT02753647 | Chidamide Plus R-CHOP in Elderly DLBCL | unknown | Phase 2 | 49 | Ruijin HospitalOTHER | 1 | Nov 14, 2017 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials